235 related articles for article (PubMed ID: 36211334)
1. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract][Full Text] [Related]
2. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
3. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles in BCL11B-siRNA treated malignant T cells.
Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
[TBL] [Abstract][Full Text] [Related]
5. Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome.
Huang X; Chen C; Zhong M; Geng S; Zhao Y; Li M; Deng C; Zeng L; Wu P; Lu Z; Weng J; Du X; Li Y
Biomark Res; 2021 Jun; 9(1):46. PubMed ID: 34112264
[TBL] [Abstract][Full Text] [Related]
6. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
[TBL] [Abstract][Full Text] [Related]
7. Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8
Helm EY; Zelenka T; Cismasiu VB; Islam S; Silvane L; Zitti B; Holmes TD; Drashansky TT; Kwiatkowski AJ; Tao C; Dean J; Obermayer AN; Chen X; Keselowsky BG; Zhang W; Huo Z; Zhou L; Sheridan BS; Conejo-Garcia JR; Shaw TI; Bryceson YT; Avram D
Sci Immunol; 2023 Apr; 8(82):eabn0484. PubMed ID: 37115913
[TBL] [Abstract][Full Text] [Related]
8. T Cell factor 1 represses CD8+ effector T cell formation and function.
Tiemessen MM; Baert MR; Kok L; van Eggermond MC; van den Elsen PJ; Arens R; Staal FJ
J Immunol; 2014 Dec; 193(11):5480-7. PubMed ID: 25355919
[TBL] [Abstract][Full Text] [Related]
9. T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
[TBL] [Abstract][Full Text] [Related]
10. HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 Jan; 19(1):42. PubMed ID: 33485349
[TBL] [Abstract][Full Text] [Related]
11. Generation of Inducible
Przybylski GK; Korsak D; Iżykowska K; Nowicka K; Zalewski T; Tubacka M; Mosor M; Januszkiewicz-Lewandowska D; Frydrychowicz M; Boruczkowski M; Dworacki G; van den Brandt J; Grabarczyk P; Schmidt CA; Zeng C; Li Y
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563322
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness.
Alsagaby SA
Saudi Med J; 2019 Apr; 40(4):328-338. PubMed ID: 30957125
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K
Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541
[TBL] [Abstract][Full Text] [Related]
14. Central memory CD8
Pais Ferreira D; Silva JG; Wyss T; Fuertes Marraco SA; Scarpellino L; Charmoy M; Maas R; Siddiqui I; Tang L; Joyce JA; Delorenzi M; Luther SA; Speiser DE; Held W
Immunity; 2020 Nov; 53(5):985-1000.e11. PubMed ID: 33128876
[TBL] [Abstract][Full Text] [Related]
15. BCL11B suppression does not influence CD34(+) cell differentiation and proliferation.
Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072
[TBL] [Abstract][Full Text] [Related]
16. T Cell Factor 1 Suppresses CD103+ Lung Tissue-Resident Memory T Cell Development.
Wu J; Madi A; Mieg A; Hotz-Wagenblatt A; Weisshaar N; Ma S; Mohr K; Schlimbach T; Hering M; Borgers H; Cui G
Cell Rep; 2020 Apr; 31(1):107484. PubMed ID: 32268106
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
18. BCL11B is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
Permatasari HK; Nakahata S; Ichikawa T; Morishita K
Biochem Biophys Res Commun; 2017 Aug; 490(3):1086-1092. PubMed ID: 28669733
[TBL] [Abstract][Full Text] [Related]
19. The role of BCL11B in regulating the proliferation of human naive T cells.
Chen S; Huang X; Chen S; Yang L; Shen Q; Zheng H; Li B; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hum Immunol; 2012 May; 73(5):456-64. PubMed ID: 22426257
[TBL] [Abstract][Full Text] [Related]
20. COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Plesingerova H; Librova Z; Plevova K; Libra A; Tichy B; Skuhrova Francova H; Vrbacky F; Smolej L; Mayer J; Bryja V; Doubek M; Pospisilova S
Leuk Lymphoma; 2017 Jan; 58(1):70-79. PubMed ID: 27185377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
